Literature DB >> 35842723

Rod-like hybrid nanomaterial with tumor targeting and pH-responsive for cancer chemo/photothermal synergistic therapy.

Shaochen Wang1, Qiaoqiao Zhou1, Shuling Yu2, Shuang Zhao1, Jiahua Shi3, Jintao Yuan4.   

Abstract

The development of chemo/photothermal nanotherapeutic systems with excellent photothermal performance, stable drug loading, tumor targeting and strong membrane penetration still remains a challenge. To address this problem, herein a rod-like nanocomposite system (AuNR@FA-PR/PEG) forming from folic acid (FA) terminated carboxylated cyclodextrin (CD) pseudopolyrotaxane (FA-PR) and polyethylene glycol (PEG) modifying gold nanorods (AuNR) was reported. Cisplatin (CDDP) was loaded in AuNR@FA-PR/PEG via coordination bonds to prepare a rod-like pH-responsive nanosystem (AuNR@FA-PR/PEG/CDDP) with chemotherapy/photothermal therapy. The rod-like morphology of AuNR@FA-PR/PEG was characterized by transmission electron microscope. In vitro drug release experiments showed the pH-responsive of AuNR@FA-PR/PEG/CDDP. In vivo real-time imaging assays proved AuNR@FA-PR/PEG/CDDP could rapidly enrich in the tumor area and stay for a long time because of folate targeting and their rod-like morphology. In vivo photothermal imaging assays showed AuNR@FA-PR/PEG/CDDP excellent photothermal performance, the average temperature of tumor region could reach 63.5 °C after 10 min irradiation. In vitro and in vivo experiments also demonstrated that the combined therapy of chemotherapy and photothermal therapy had an outstandingly synergistic effect and improved the therapeutic efficacy comparing with chemotherapy and photothermal therapy alone. Therefore, the prepared rod-like AuNR@FA-PR/PEG/CDDP will provide a new strategy for the effective treatment of cancer.
© 2022. The Author(s).

Entities:  

Keywords:  Gold nanorods; Hybrid nanomaterials; Polyrotaxane; Targeted synergistic therapy; pH-Responsive

Mesh:

Substances:

Year:  2022        PMID: 35842723      PMCID: PMC9287864          DOI: 10.1186/s12951-022-01527-1

Source DB:  PubMed          Journal:  J Nanobiotechnology        ISSN: 1477-3155            Impact factor:   9.429


  25 in total

Review 1.  Plasmonic photothermal therapy (PPTT) using gold nanoparticles.

Authors:  Xiaohua Huang; Prashant K Jain; Ivan H El-Sayed; Mostafa A El-Sayed
Journal:  Lasers Med Sci       Date:  2007-08-03       Impact factor: 3.161

Review 2.  Thermal therapy, part 1: an introduction to thermal therapy.

Authors:  Riadh W Y Habash; Rajeev Bansal; Daniel Krewski; Hafid T Alhafid
Journal:  Crit Rev Biomed Eng       Date:  2006

3.  Synthesis of paclitaxel-conjugated β-cyclodextrin polyrotaxane and its antitumor activity.

Authors:  Shuling Yu; Yajun Zhang; Xin Wang; Xu Zhen; Zhaoheng Zhang; Wei Wu; Xiqun Jiang
Journal:  Angew Chem Int Ed Engl       Date:  2013-06-05       Impact factor: 15.336

4.  Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy.

Authors:  Kai Yang; Shuai Zhang; Guoxin Zhang; Xiaoming Sun; Shuit-Tong Lee; Zhuang Liu
Journal:  Nano Lett       Date:  2010-09-08       Impact factor: 11.189

Review 5.  Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy.

Authors:  Hanieh Mousazadeh; Younes Pilehvar-Soltanahmadi; Mehdi Dadashpour; Nosratollah Zarghami
Journal:  J Control Release       Date:  2020-11-11       Impact factor: 9.776

6.  Co-assembled gold nanorod@tripeptide core-shell nanospheres for aqueous Hg2+ removal.

Authors:  Xingcen Liu; Jin Yuan; Zhuo Zhang; Zhaohui Huang; Jingcheng Hao
Journal:  J Colloid Interface Sci       Date:  2021-04-21       Impact factor: 8.128

Review 7.  Cancer theranostics with near-infrared light-activatable multimodal nanoparticles.

Authors:  Marites P Melancon; Min Zhou; Chun Li
Journal:  Acc Chem Res       Date:  2011-08-17       Impact factor: 22.384

8.  A novel electrochemiluminescent immunoassay for diclofenac using conductive polymer functionalized graphene oxide as labels and gold nanorods as signal enhancers.

Authors:  Chao Wang; Tingxiang Jiang; Kang Zhao; Anping Deng; Jianguo Li
Journal:  Talanta       Date:  2018-10-09       Impact factor: 6.057

Review 9.  Research progress of tumor targeted drug delivery based on PD-1/PD-L1.

Authors:  Dongzhu Liu; Shan Gao; Yujia Zhai; Xiaoye Yang; Guangxi Zhai
Journal:  Int J Pharm       Date:  2022-01-30       Impact factor: 5.875

10.  Polyrotaxane-based supramolecular theranostics.

Authors:  Guocan Yu; Zhen Yang; Xiao Fu; Bryant C Yung; Jie Yang; Zhengwei Mao; Li Shao; Bin Hua; Yijing Liu; Fuwu Zhang; Quli Fan; Sheng Wang; Orit Jacobson; Albert Jin; Changyou Gao; Xiaoying Tang; Feihe Huang; Xiaoyuan Chen
Journal:  Nat Commun       Date:  2018-02-22       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.